SIGYN THERAPEUTICS, INC. Convertible Notes Payable, Current
SIGYN THERAPEUTICS, INC. (SIGY) had Convertible Notes Payable, Current of $2.51 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2025-11-14
- 2025-09-30: Convertible Notes Payable, Current $2.51M.
- 2025-06-30: Convertible Notes Payable, Current $2.31M.
- 2025-03-31: Convertible Notes Payable, Current $2.19M.
- 2024-12-31: Convertible Notes Payable, Current $1.89M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2025-09-30 | $2.51M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.31M 10-Q · filed 2025-09-05 |
| 2025-03-31 | $2.19M 10-Q · filed 2025-05-20 |
| 2024-12-31 | $1.89M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $1.79M 10-Q · filed 2024-11-19 |
| 2024-06-30 | $1.78M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $2.48M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.21M 10-K · filed 2025-04-15 |
| 2023-09-30 | $2.95M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.63M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.47M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.64M 10-K · filed 2024-02-20 |
| 2022-09-30 | $1.52M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $945.22K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $704.92K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $647.20K 10-K · filed 2023-03-31 |
| 2021-09-30 | $684.74K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $621.30K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $578.25K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $518.67K 10-K · filed 2022-03-21 |
| 2020-09-30 | $1.80M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.80M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $1.80M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $1.80M 10-Q · filed 2020-11-09 |
| 2019-09-30 | $1.77M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.73M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $1.73M 10-Q · filed 2019-04-19 |
| 2018-12-31 | $1.73M 10-K · filed 2020-03-30 |
| 2017-12-31 | $1.21M 10-K · filed 2019-04-01 |